Vrati se na sadržaj

Beta talasemija major

Farmakološka indukcija sinteze fetalnog hemoglobina

Terapija (hidroksikarabamidom) hidroksiureom

Efficacy of hydroxyurea in providing transfusion independence in β-thalassemia. (otvara novi prozor)

Ansari SH, Shamsi TS, Ashraf M, Perveen K, Farzana T, Bohray M, Erum S, Mehboob T.

Izvor‎: J Pediatr Hematol Oncol 2011;33(5):339-43.

Indeks‎: PubMed 21602718

DOI‎: 10.1097/MPH.0b013e31821b0770

https://www.ncbi.nlm.nih.gov/pubmed/21602718 (otvara novi prozor)

Decreased transfusion needs associated with hydroxyurea therapy in Algerian patients with thalassemia major or intermedia. (otvara novi prozor)

Bradai M, Pissard S, Abad MT, Dechartres A, Ribeil JA, Landais P, de Montalembert M.

Izvor‎: Transfusion 2007;47(10):1830-6.

Indeks‎: PubMed 17880608

DOI‎: 10.1111/j.1537-2995.2007.01399.x

https://www.ncbi.nlm.nih.gov/pubmed/17880608 (otvara novi prozor)

Hydroxyurea increases hemoglobin F levels and improves the effectiveness of erythropoiesis in beta-thalassemia/hemoglobin E disease. (otvara novi prozor)

Fucharoen S, Siritanaratkul N, Winichagoon P, Chowthaworn J, Siriboon W, Muangsup W, Chaicharoen S, Poolsup N, Chindavijak B, Pootrakul P, Piankijagum A, Schechter AN, Rodgers GP.

Izvor‎: Blood 1996;87(3):887-92.

Indeks‎: PubMed 8562958

https://www.ncbi.nlm.nih.gov/pubmed/8562958 (otvara novi prozor)

Genotype-phenotype relationship of patients with β-thalassemia taking hydroxyurea: a 13-year experience in Iran. (otvara novi prozor)

Karimi M, Haghpanah S, Farhadi A, Yavarian M.

Izvor‎: Int J Hematol 2012;95(1):51-6.

Indeks‎: PubMed 22180324

DOI‎: 10.1007/s12185-011-0985-6

https://www.ncbi.nlm.nih.gov/pubmed/22180324 (otvara novi prozor)

Clinical experience with fetal hemoglobin induction therapy in patients with β-thalassemia. (otvara novi prozor)

Musallam KM, Taher AT, Cappellini MD, Sankaran VG.

Izvor‎: Blood 2013;121(12):2199-212.

Indeks‎: PubMed 23315167

DOI‎: 10.1182/blood-2012-10-408021

https://www.ncbi.nlm.nih.gov/pubmed/23315167 (otvara novi prozor)

A randomised double-blind placebo-controlled clinical trial of oral hydroxyurea for transfusion-dependent β-thalassaemia. (otvara novi prozor)

Yasara N, Wickramarathne N, Mettananda C, Silva I, Hameed N, Attanayaka K, Rodrigo R, Wickramasinghe N, Perera L, Manamperi A, Premawardhena A, Mettananda S

Izvor‎: Sci Rep. 2022;12(1):2752.

Indeks‎: PubMed 35177777

DOI‎: 10.1038/s41598-022-06774-8

https://pubmed.ncbi.nlm.nih.gov/35177777/ (otvara novi prozor)

Response to hydroxyurea treatment in Iranian transfusion-dependent beta-thalassemia patients. (otvara novi prozor)

Yavarian M, Karimi M, Bakker E, Harteveld CL, Giordano PC.

Izvor‎: Haematologica 2004;89(10):1172-8.

Indeks‎: PubMed 15477200

https://www.ncbi.nlm.nih.gov/pubmed/15477200 (otvara novi prozor)

Hydroxyurea therapy in 49 patients with major beta-thalassemia. (otvara novi prozor)

Zamani F, Shakeri R, Eslami SM, Razavi SM, Basi A.

Izvor‎: Arch Iran Med 2009;12(3):295-7.

Indeks‎: PubMed 19400608

https://www.ncbi.nlm.nih.gov/pubmed/19400608 (otvara novi prozor)

Rekombinovani eritropoetin (sam ili u kombinaciji sa drugim lekovima)

Induction of fetal hemoglobin synthesis with recombinant human erythropoietin in anemic patients with heterozygous beta-thalassemia during pregnancy. (otvara novi prozor)

Breymann C, Fibach E, Visca E, Huettner C, Huch A, Huch R.

Izvor‎: J Matern Fetal Med 1999;8(1):1-7.

Indeks‎: PubMed 10052837

DOI‎: 10.1002/(SICI)1520-6661(199901/02)8:1<1::AID-MFM1>3.0.CO;2-O

https://www.ncbi.nlm.nih.gov/pubmed/10052837 (otvara novi prozor)

Treatment of beta-thalassemia patients with recombinant human erythropoietin: effect on transfusion requirements and soluble adhesion molecules. (otvara novi prozor)

Chaidos A, Makis A, Hatzimichael E, Tsiara S, Gouva M, Tzouvara E, Bourantas KL.

Izvor‎: Acta Haematol 2004;111(4):189-95.

Indeks‎: PubMed 15153710

DOI‎: 10.1159/000077551

https://www.ncbi.nlm.nih.gov/pubmed/15153710 (otvara novi prozor)

Fetal globin induction--can it cure beta thalassemia? (otvara novi prozor)

Perrine SP.

Izvor‎: Hematology Am Soc Hematol Educ Program 2005:38-44.

Indeks‎: PubMed 16304357

DOI‎: 10.1182/asheducation-2005.1.38

https://www.ncbi.nlm.nih.gov/pubmed/16304357 (otvara novi prozor)